Last updated: 11/16/2021 13:40:04

Post-Market Clinical Follow-Up (PMCF) Study for Otrivin Sea Water pressurised sprays (with and without Aloe Vera)

GSK study ID
217004
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Observational, questionnaire-based, Post-Market Clinical Follow-Up (PMCF) Study for Otrivin Sea Water pressurised sprays (with and without Aloe Vera)
Trial description: The main aim of this study is to confirm the safety and performance of Otrivin Sea Water pressurised spray (with and without Aloe Vera) post-Certification Europe (CE) Mark for their respective indicated population, in accordance with (EU) MDR 2017/745 Annex XIV Part B and the guidance document MDCG 2020-7 PMCF Plan Template - A guide for manufacturers and notified bodies
(April 2020).
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Proportion of Participants Reported Adverse Events (AEs) and Serious Adverse Events (SAEs) While Using the Otrivin Sea Water Pressurised Sprays (With and Without Aloe Vera) During Survey Period

Timeframe: Approximately 1 year

Percentage of Participants Reported satisfaction on a 5-point scale Questionnaire

Timeframe: Approximately 1 year

Secondary outcomes:
Not applicable
Interventions:
  • Device: Otrivin Sea Water with Aloe Vera
  • Device: Otrivin Sea Water without Aloe Vera
  • Enrollment:
    1110
    Primary completion date:
    2021-04-10
    Observational study model:
    Ecologic or Community
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Common cold
    Product
    Not applicable
    Collaborators
    Not applicable
    Study date(s)
    July 2021 to October 2021
    Type
    Observational
    Phase
    4

    Participation criteria

    Sex
    Female & Male
    Age
    0 - 99 Years
    Accepts healthy volunteers
    Yes
    • Inclusion Criteria
    • Participant is deemed suitable for inclusion in the investigation if both the following criteria are met :

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    online survey
    online survey, NA, Norway, NA
    Status
    Study Complete

    Study documents

    No study documents available.

    Results overview

    No study documents available

    Recruitment status
    Study complete
    Actual primary completion date
    2021-04-10
    Actual study completion date
    2021-04-10

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website